Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting

Treatment with either nifedipine or labetalol is equally effective in controlling blood pressure (BP) among women with hypertension during pregnancy, with no adverse effects on perinatal outcomes, according to the Giant PANDA* trial presented at SMFM 2026.

A prospective quasi-randomized controlled trial presented at SMFM 2026 has demonstrated the potential of transcutaneous electrical nerve stimulation (TENS) to reduce postoperative pain following Caesarean delivery.

Most women on antidepressant therapy discontinue their medications during pregnancy despite guideline recommendations against doing so, and this practice results in more mental health emergencies, according to new research.

In new mothers who had gestational hypertension or pre-eclampsia, initiating blood pressure (BP)-lowering therapy at a threshold of 140/90 mm Hg helps improve early postpartum BP control and reduce the incidence of severe hypertension, although it does not translate to a reduction in related hospital readmissions, according to a study.

Children born to mothers who received adjunctive azithromycin prophylaxis for caesarean delivery are less likely to become obese later in life than their counterparts who received a placebo, according to the follow-up study of the C/SOAP* trial presented at SMFM 2026.